Phase 3, Open Label, Multi-centre, Randomised Controlled International Study in Ewing Sarcoma.
Phase of Trial: Phase III
Latest Information Update: 16 Jul 2018
At a glance
- Drugs Busulfan (Primary) ; Fenretinide (Primary) ; Treosulfan (Primary) ; Zoledronic acid (Primary) ; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Ifosfamide; Melphalan; Mesna; Vincristine
- Indications Ewing's sarcoma
- Focus Therapeutic Use
- Acronyms EWING2008
- 19 May 2016 Planned End Date changed from 1 Mar 2018 to 1 Mar 2019 as reported by ClinicalTrials.gov.
- 19 May 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Mar 2019, as reported by ClinicalTrials.gov.
- 06 Jul 2012 Additional lead trial centre identified as reported by German Clinical Trials Register.